Swedencare AB (SWDCF)
2.30
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Swedencare EPS Diluted (Quarterly) : 0.0158 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0158 |
| March 31, 2026 | 0.0121 |
| December 31, 2025 | 0.0109 |
| September 30, 2025 | 0.0146 |
| June 30, 2025 | -0.0045 |
| March 31, 2025 | 0.0141 |
| December 31, 2024 | 0.0139 |
| September 30, 2024 | 0.0145 |
| June 30, 2024 | 0.0123 |
| March 31, 2024 | 0.0182 |
| December 31, 2023 | -0.0077 |
| September 30, 2023 | 0.0222 |
| June 30, 2023 | 0.0097 |
| March 31, 2023 | 0.0104 |
| December 31, 2022 | 0.0093 |
| September 30, 2022 | 0.0023 |
| June 30, 2022 | 0.0387 |
| March 31, 2022 | 0.0107 |
| December 31, 2021 | 0.0188 |
| September 30, 2021 | 0.0106 |
| June 30, 2021 | 0.0171 |
| March 31, 2021 | 0.002 |
| December 31, 2020 | 0.0085 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0188 |
| June 30, 2020 | 0.0067 |
| March 31, 2020 | 0.011 |
| December 31, 2019 | 0.0075 |
| September 30, 2019 | 0.0117 |
| June 30, 2019 | 0.0091 |
| March 31, 2019 | 0.0118 |
| December 31, 2018 | 0.0081 |
| September 30, 2018 | 0.0098 |
| June 30, 2018 | 0.0085 |
| March 31, 2018 | 0.0074 |
| December 31, 2017 | 0.0079 |
| September 30, 2017 | 0.0069 |
| June 30, 2017 | 0.0032 |
| March 31, 2017 | 0.0074 |
| December 31, 2016 | 0.0009 |
| September 30, 2016 | 0.0049 |
| June 30, 2016 | 0.0041 |
| March 31, 2016 | 0.005 |
| December 31, 2015 | -0.0004 |
| September 30, 2015 | 0.0036 |
| June 30, 2015 | 0.0044 |
| March 31, 2015 | 0.0028 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orexo AB | -0.3052 |
| Camurus AB | 0.432 |
| Moberg Pharma AB | -0.0075 |
| Infant Bacterial Therapeutics AB | -0.1863 |
| AstraZeneca PLC | 0.9849 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.531M |
| Revenue (Quarterly) | 71.55M |
| Total Expenses (Quarterly) | 69.02M |
| Enterprise Value | 540.81M |
| Gross Profit Margin (Quarterly) | 7.63% |
| Profit Margin (Quarterly) | 3.54% |
| Earnings Yield | 2.32% |
| Operating Earnings Yield | 5.09% |
| Normalized Earnings Yield | 2.322 |